Activity Details

Free CME
0.75 AMA PRA Category 1 Credit(s)
Released: August 7, 2019
Expires: August 6, 2020
45 minutes to complete

Provider Statement

This continuing medical education activity is provided by

Support Statement

This activity is supported by an educational grant from Aimmune Therapeutics, Inc.

Activity Chair

Ruchi S. Gupta, MD, MPH
Professor of Pediatrics and Medicine
Northwestern Feinberg School of Medicine
Director, Science and Outcomes of Allergy and Asthma Research Team
Clinical Attending
Ann and Robert H. Lurie Children's Hospital Chicago
Chicago, IL
  • Disclosures:
    Consulting Fee: Aimmune, BEFORE Brands, DBV Technologies, Kaleo Pharma
    Contracted Research: Thermo Fisher Scientific, United Health Group


Aikaterini Anagnostou, MD (Hons), MSc, PhD
Associate Professor of Pediatric Allergy
Director, Food Immunotherapy Program
Associate Director, Food Allergy Program
Immunology, Allergy and Rheumatology
Texas Children's Hospital
Baylor College of Medicine
Houston, TX
  • Disclosures:
    Contracted Research (paid to institution): Aimmune

Christina E. Ciaccio, MD, MSc
Associate Professor of Pediatrics
Section Chief
Allergy/Immunology and Pediatric Pulmonology and Sleep Medicine
University of Chicago Medicine
Chicago, IL
  • Disclosures:
    Consulting Fee: Aimmune, Regeneron
    Speakers Bureau: Aimmune
    Contracted Research: Aimmune, Astellas, DBV Technologies, Sanofi

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosures: No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, August 7, 2019 to August 6, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the video, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 67% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


The prevalence of food allergy has been increasing, especially among children, with nearly 1 in 13 children in the United States being impacted. Peanut allergy, in particular, has attracted growing attention in recent years as it has become increasingly common. Despite this, there are no approved treatments specifically for food allergy, and standard immunotherapy has limitations. This CME activity will assess the latest clinical evidence regarding new or late-stage oral immunotherapy options for peanut allergy management and will feature the most recent data from the 2019 European Academy of Allergy and Clinical Immunology (EAACI) Congress.

Target Audience

The intended audience for the activity is allergists, immunologists, and other health care professionals involved in the management of patients with peanut allergy.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess the latest clinical evidence regarding new or late-stage oral immunotherapy options for peanut allergy management.
  • Review the potential impact of raising the peanut allergen threshold on patient quality of life and/or the need for emergent care.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.